Evidence map›Paper›PMID 33595789›Full record

ArticleJapanese journal of radiology2021

Comparison of three freeware software packages for

Michele Larobina, Rosario Megna, Raffaele Solla

Abstract readComparative StudyEvaluation Study
PubMed Publisher
In one paragraph

Article in Japanese journal of radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michele LarobinaInstitute of Biostructures and Bioimaging, National Research Council (CNR), Via Tommaso de Amicis, 95, 80145, Napoli, Italy.
Rosario MegnaInstitute of Biostructures and Bioimaging, National Research Council (CNR), Via Tommaso de Amicis, 95, 80145, Napoli, Italy. rosario.megna@cnr.it.ORCID http://orcid.org/0000-0002-5716-2137
Raffaele SollaInstitute of Biostructures and Bioimaging, National Research Council (CNR), Via Tommaso de Amicis, 95, 80145, Napoli, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo compare texture feature estimates obtained from

methodsPET images from 15 patients with head and neck cancer were processed with three different freeware software: CGITA, LIFEx, and Metavol. For each lesion, 38 texture features were extracted from each software package. To evaluate the statistical agreement among the features across packages a non-parametric Kruskal-Wallis test was used. Differences in the features between each couple of software were assessed using a subsequent Dunn test. Correlation between texture features was evaluated via the Spearman coefficient.

resultsTwenty-three of 38 features showed a significant agreement across the three software (P < 0.05). The agreement was better between LIFEx vs. Metavol (36 of 38) and worse between CGITA and Metavol (24 of 38), and CGITA vs. LIFEx (23 of 38). All features resulted correlated (ρ >  = 0.70, P < 0.001) in comparing LIFEx vs. Metavol. Seven of 38 features were found not in agreement and slightly or not correlated (ρ < 0.70, P < 0.001) in comparing CGITA vs. LIFEx, and CGITA vs. Metavol.

conclusionSome texture discrepancies across software packages exist. Our findings reinforce the need to continue the standardization process, and to succeed in building a reference dataset to be used for comparisons.

Indexed as

Fluorodeoxyglucose F18Software ValidationAgedFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedPhantoms, ImagingPositron Emission Tomography Computed TomographyRadiographic Image EnhancementFluorodeoxyglucose F18OncologyPositron emission tomographyRadiomicsTexture

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.